Subsidiary gets extra GST penalty of 1.79 crore from Gujarat tax office

Regulatory & Legal View source PDF Explain this filing

AKUMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.4%Reaction day

₹422.10

prior close

₹420.80

announcement price

In-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.6%+0.3% vs market

Pharmaceuticals peers, median of 159sector-0.4%+0.1% vs sector

On the reaction day the stock moved 0.3 pts more than Nifty Microcap 250 and 0.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.1

15m

+0.1

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.4-0.6+0.3-0.4+0.1

Next day

-0.2-1.5+1.4-1.3+1.2

+0.0-1.8+1.8-1.3+1.3

+1.4-0.6+2.0-0.4+1.8

+5.4+0.8+4.7+0.1+5.4

+6.3+0.8+5.5+0.2+6.1

+6.6-0.2+6.8-0.7+7.3

15d

+8.0+1.1+6.9+0.9+7.1

+5.2-3.5+8.7-2.6+7.8

+13.0-3.2+16.3-4.3+17.3

+9.5-12.8+22.2-11.5+21.0

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Akums Drugs wholly-owned subsidiary Maxcure Nutravedics received an additional penalty of 1.79 crore from the Gujarat State Tax office under Section 129(3) of the CGST Act, due to a wrongly entered shipping address in an October 2025 invoice and e-way bill. Combined with the earlier order, the total GST penalty impact now stands at 3.59 crore. The company calls it not material to its finances.

Likely market impact

Total GST penalties on subsidiary now 3.59 crore; company says impact is not material.